Dana Ravid

724 total citations
8 papers, 600 citations indexed

About

Dana Ravid is a scholar working on Cell Biology, Molecular Biology and Physiology. According to data from OpenAlex, Dana Ravid has authored 8 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cell Biology, 6 papers in Molecular Biology and 2 papers in Physiology. Recurrent topics in Dana Ravid's work include Caveolin-1 and cellular processes (7 papers), Metabolism, Diabetes, and Cancer (4 papers) and Erythrocyte Function and Pathophysiology (2 papers). Dana Ravid is often cited by papers focused on Caveolin-1 and cellular processes (7 papers), Metabolism, Diabetes, and Cancer (4 papers) and Erythrocyte Function and Pathophysiology (2 papers). Dana Ravid collaborates with scholars based in Israel and United States. Dana Ravid's co-authors include Mordechai Liscovitch, Reuven Reich, Giusy Fiucci, Haim Werner, Sharon Maor, Yaakov Lavie, Dana Chuderland, Limor Landsman, Robert A. Lamb and George P. Leser and has published in prestigious journals such as Oncogene, Journal of Virology and FEBS Letters.

In The Last Decade

Dana Ravid

8 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dana Ravid Israel 8 403 337 117 116 59 8 600
Eri Asano Japan 15 375 0.9× 159 0.5× 100 0.9× 86 0.7× 18 0.3× 18 510
Marta Stasiak Poland 13 259 0.6× 121 0.4× 98 0.8× 82 0.7× 29 0.5× 19 501
Patricia Ambroziak United States 8 550 1.4× 132 0.4× 127 1.1× 47 0.4× 31 0.5× 8 706
Keiko Ishino Japan 12 415 1.0× 104 0.3× 107 0.9× 77 0.7× 19 0.3× 20 535
Kathrin Laaß Germany 7 655 1.6× 112 0.3× 109 0.9× 139 1.2× 46 0.8× 7 797
Adeline Ledoux United Kingdom 8 341 0.8× 96 0.3× 126 1.1× 142 1.2× 26 0.4× 10 545
Oleg V. Chaika United States 12 500 1.2× 83 0.2× 90 0.8× 53 0.5× 46 0.8× 16 619
Sonia Pacini Italy 8 399 1.0× 113 0.3× 75 0.6× 54 0.5× 63 1.1× 9 617
Gary Guo United States 8 325 0.8× 153 0.5× 204 1.7× 44 0.4× 38 0.6× 10 554
Claudia Tredup Germany 10 219 0.5× 122 0.4× 69 0.6× 80 0.7× 21 0.4× 15 415

Countries citing papers authored by Dana Ravid

Since Specialization
Citations

This map shows the geographic impact of Dana Ravid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Ravid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Ravid more than expected).

Fields of papers citing papers by Dana Ravid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Ravid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Ravid. The network helps show where Dana Ravid may publish in the future.

Co-authorship network of co-authors of Dana Ravid

This figure shows the co-authorship network connecting the top 25 collaborators of Dana Ravid. A scholar is included among the top collaborators of Dana Ravid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Ravid. Dana Ravid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ravid, Dana, George P. Leser, & Robert A. Lamb. (2010). A Role for Caveolin 1 in Assembly and Budding of the Paramyxovirus Parainfluenza Virus 5. Journal of Virology. 84(19). 9749–9759. 27 indexed citations
2.
Ravid, Dana, Dana Chuderland, Limor Landsman, et al.. (2008). Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration. Experimental Cell Research. 314(15). 2762–2773. 58 indexed citations
3.
Ravid, Dana, Sharon Maor, Haim Werner, & Mordechai Liscovitch. (2006). Caveolin-1 inhibits anoikis and promotes survival signaling in cancer cells. Advances in Enzyme Regulation. 46(1). 163–175. 35 indexed citations
4.
Ravid, Dana, et al.. (2006). Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways. Experimental Cell Research. 312(19). 3899–3908. 26 indexed citations
5.
Ravid, Dana, et al.. (2006). Caveolin‐1 controls BRCA1 gene expression and cellular localization in human breast cancer cells. FEBS Letters. 580(22). 5268–5274. 18 indexed citations
6.
Liscovitch, Mordechai & Dana Ravid. (2006). A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells. Cancer Letters. 245(1-2). 350–352. 126 indexed citations
7.
Ravid, Dana, Sharon Maor, Haim Werner, & Mordechai Liscovitch. (2004). Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling. Oncogene. 24(8). 1338–1347. 81 indexed citations
8.
Fiucci, Giusy, Dana Ravid, Reuven Reich, & Mordechai Liscovitch. (2002). Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene. 21(15). 2365–2375. 229 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026